Well in line with histology, the tumor showed expression of both glial (e.g. GFAP) and neuronal markers (e.g. synaptophysin) with pathological expression of CD34 and retained ATRX expression (Fig. 2). The gene discussed is ATRX; the disease is neoplasm.